These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 17034469)
1. Muir-Torre syndrome: Diagnostic and screening guidelines. Jones B; Oh C; Mangold E; Egan CA Australas J Dermatol; 2006 Nov; 47(4):266-9. PubMed ID: 17034469 [TBL] [Abstract][Full Text] [Related]
2. An illustrative case of Muir-Torre syndrome: contribution of immunohistochemical analysis in identifying indicator sebaceous lesions. Marazza G; Masouyé I; Taylor S; Prins C; Gaudin T; Saurat JH; French LE Arch Dermatol; 2006 Aug; 142(8):1039-42. PubMed ID: 16924054 [TBL] [Abstract][Full Text] [Related]
3. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714 [TBL] [Abstract][Full Text] [Related]
4. [Muir-Torre syndrome and familial colorectal cancer: 2 families with molecular genetic analysis]. Doré MX; Dieumegard B; Grandjouan S; Avril MF; Martinet C; Ducreux M; Lasser P; Bressac-de Paillerets B Ann Dermatol Venereol; 1999; 126(8-9):582-6. PubMed ID: 10530344 [TBL] [Abstract][Full Text] [Related]
5. The frequency of Muir-Torre syndrome among Lynch syndrome families. South CD; Hampel H; Comeras I; Westman JA; Frankel WL; de la Chapelle A J Natl Cancer Inst; 2008 Feb; 100(4):277-81. PubMed ID: 18270343 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous Sebaceous Lesions in a Patient With MUTYH-Associated Polyposis Mimicking Muir-Torre Syndrome. Kacerovska D; Drlik L; Slezakova L; Michal M; Stehlik J; Sedivcova M; Hadravsky L; Kazakov DV Am J Dermatopathol; 2016 Dec; 38(12):915-923. PubMed ID: 27870730 [TBL] [Abstract][Full Text] [Related]
7. A novel complex mutation in MSH2 contributes to both Muir-Torre and Lynch Syndrome. Perera S; Ramyar L; Mitri A; Pollett A; Gallinger S; Speevak MD; Aronson M; Bapat B J Hum Genet; 2010 Jan; 55(1):37-41. PubMed ID: 19911012 [TBL] [Abstract][Full Text] [Related]
16. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. Kruse R; Rütten A; Schweiger N; Jakob E; Mathiak M; Propping P; Mangold E; Bisceglia M; Ruzicka T J Invest Dermatol; 2003 May; 120(5):858-64. PubMed ID: 12713593 [TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability in Muir-Torre syndrome. Honchel R; Halling KC; Schaid DJ; Pittelkow M; Thibodeau SN Cancer Res; 1994 Mar; 54(5):1159-63. PubMed ID: 8118799 [TBL] [Abstract][Full Text] [Related]
18. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening. Julié C; Trésallet C; Brouquet A; Vallot C; Zimmermann U; Mitry E; Radvanyi F; Rouleau E; Lidereau R; Coulet F; Olschwang S; Frébourg T; Rougier P; Nordlinger B; Laurent-Puig P; Penna C; Boileau C; Franc B; Muti C; Hofmann-Radvanyi H Am J Gastroenterol; 2008 Nov; 103(11):2825-35; quiz 2836. PubMed ID: 18759827 [TBL] [Abstract][Full Text] [Related]
19. [Muir-Torre syndrome and HNPCC: importance of clinical diagnosis and genetic investigation in family members]. Strul H; Rozen P; Naiman T; Shomrat R Harefuah; 1999 Feb; 136(4):274-6, 339. PubMed ID: 10914216 [TBL] [Abstract][Full Text] [Related]
20. Sebaceous neoplasms and the immunoprofile of mismatch-repair proteins as a screening target for syndromic cases. Boennelycke M; Thomsen BM; Holck S Pathol Res Pract; 2015 Jan; 211(1):78-82. PubMed ID: 25457183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]